⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TSHA News
Taysha Gene Therapies, Inc. Common Stock
Taysha Gene Therapies Reports Full-Year 2025 Financial Results and Provides Corporate Update
globenewswire.com
TSHA
Taysha Gene Therapies to Release Full-Year 2025 Financial Results and Host Conference Call and Webcast on March 19
globenewswire.com
TSHA
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
TSHA
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
TSHA
Taysha Gene Therapies Announces Progress Across TSHA-102 Pivotal Gene Therapy Program in Rett Syndrome
globenewswire.com
TSHA
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
TSHA
Taysha Gene Therapies Reports Third Quarter 2025 Financial Results and Provides Corporate Update
globenewswire.com
TSHA
Taysha Gene Therapies to Release Third Quarter 2025 Financial Results and Host Conference Call and Webcast on November 4
globenewswire.com
TSHA
Taysha Gene Therapies Regains Full Rights to Lead TSHA-102 Program in Clinical Evaluation for the Treatment of Rett Syndrome
globenewswire.com
TSHA
Taysha Gene Therapies Presents New Supplemental Data Analysis from Part A of the REVEAL Phase 1/2 Trials for TSHA-102 in Rett Syndrome at the 54th CNS Annual Meeting
globenewswire.com
TSHA